Member Info for RNmyS

A company like Avacta will be pushed in whatever direction is decided by the mms. EU registration and orders due “shortly”, I’m sure they’re keen to pick up as many cheap shares as possible. RSI now indicating this is majorly oversold, IMO we move north from here.

"100% sensitivity for identifying infectious individuals" - wording is key

As per the Avacta presentation, "infectious" was defined to be at a CT value of up to 27. Therefore the LFT has a 100% sensitivity within the infectious range.

Explained by Dr Smith here: https://www.youtube.com/watch?v=QKc7VuKzP1Y&t=893s

https://twitter.com/MDaaaamon/status/1400141764435099652?s=20

Was so concerned this morning, that I added. TBH, I wished there had been more of a dip, but hey ho https://youtu.be/TnlPtaPxXfc

News soon? I'm feeling it

Well he's now made his account private. Seems like a genuine guy based on his LinkedIn profile, so while he may have been at times a "subtle deramper", I'd like to think that he did not act with nefarious intentions.

The email also states, "Please create a new application and include the correct conformity assessment as per the regulatory route the device conforms to, and pay the association fee". This is worded as if he has the ability to do so, therefore, suggesting he may have given off the impression he was with Mologic / Avacta.

Regardless now, this does feel like it requires some explanation. I'm honestly just annoyed I added a couple of days back and not today. Missed opportunity imo

It is worth noting that we've been through some major changes though since September of last year. Many, if not all, of us were of the impression we'd have a Saliva LFT launched in 2020 but plans changed.

Very interesting, thanks for sharing PL

125% upside since the 10th of December Da-Doo-Ron-Ron...

Well his message , "Tomorrow" was sent this morning so....

Sujood

Posted in: AVCT

Posts: 988

Price: 258.00

Strong Buy

Tomorrow20 May 2021 00:12
I did say last week
But a few crap happened long story beside it will possibly get blocked lol.
Like I was blocked for a few days.
Now I can text again, in the nick of time.
What can I say, not much.
But I'm allowed to say tomorrow.
Wink wink.

Make of that what you will.

Parateeeeee

On the subject of the RSPT test, I find it very odd that older versions of the website state vastly different s/s figures for the RSPT test:
Old site: 92% specificity 96% sensitivity
(source: http://web.archive.org/web/20201114022131/https://medusa19.com/)
New site: 98% specificity 92% sensitivity
(source: https://www.medusa19.com/en/)

I can't believe they honestly mixed them up, can they..?

Important to note that was in reference to the RSPT test though Zoom. IMO as soon as we are CE marked they will place all of their focus of the AffiDX test though as the other they are producing is note great (92%sens, 98%spec)

https://twitter.com/boy_cellar/status/1393550775503183876?s=20

Great concise post though, Thanks TEMPLAR

See thread titled "BA", already been discussed

Exactly IaB, almost none of the existing home tests are CE marked for home use: https://twitter.com/BigBiteNow/status/1387714692261548032?s=20

"Let us assume it is the best singing and dancing LFT ever known to man", Can you read Simon? The test data has been available for some time now and spoilers, it is, there isn't a requirement for assumptions.

1. Manufacturing has already begun, GAD have already been, "producing the first commercial batches" of the test.
2. Commercial rollout will be imminent, alongside the CE marketing, this has been made clear.
3. Your margins are retar***. We're obviously going to be receiving larger margins than the glue gun factory.
4. 2020 revenues mean absolutely nothing. The entire value of this company comes from future revenues and IP.
5. AVA6000 only requires a phase 2 study, phase 3 will not be required: https://www.youtube.com/watch?v=lzenLmpNhxs&t=1514s

Your post only proves your lack of understanding for this business. I suggest you take some time to read the plethora of information which is available before sharing your opinions in the future.